Search Results

Your search matched 11 results

#1

The 2021 Health Trends Series | Perspectives

As we worked with providers, innovators and experts around the world to understand the trends most likely to drive change in life science clinical and commercial engagement, twenty quickly stood out.

#2

Fierce Pharma Marketing Tees up Trends for 2021—and Big News, They're Not All COVID-19-Related | In The Media

In this Fierce Pharma article, Leigh Householder at Syneos Health, shares: “It really is a pivot point.

#3

The U.S. | Blog

Democrats have revealed that the next major legislative package—colloquially known as the infrastructure package—will likely include provisions to lower prescription drug prices.

#4

A Cookie-Free World, or What You Can Do to Avoid Putting Your Marketing Efforts on a Diet | Blog

At Adexchanger’s recent Identity Day, part of a virtual series about trends in data-driven marketing, one hot topic was the announcement of the end of third-party cookies from Google.

#5

Fresh Stats—Pharma/Healthcare Digital Ad Spend | Blog

eMarketer’s latest numbers on Pharma’s digital ad spend are in, and the word of the day is growth.

#6

Hey Siri, What’s New in Voice Search? | Blog

Digital assistants are increasingly finding their way into most homes and as a result, voice searches are changing the way brands think of SEO.

#7

Trends Changing Healthcare | Blog

Live from Cannes Lions Health: Andrea Bell, Director of Insight and Executive Editor at WGSN, shared her perspective on the top five trends changing healthcare.

#8

The Implications of Classifying Video Game Addiction | Blog

Recently, the World Health Organization classified “video game addiction” as a mental health disorder.

#9

Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires | In The Media

Seasoned Talent to Drive Expansion of Solutions at the Intersection of Value and Policy

#11

The Week That Was: Hiccups, ICER and IPI | Blog

How will the Institute for Clinical and Economic Review (ICER) reconcile the tug-of-war between the promise and uncertainty in valuing gene therapies?